Can Kratom (Mitragyna speciosa) Alleviate COVID-19 Pain? A Case Study

Antonio Metastasio; Elisabeth Prevete; Darshan Singh; Oliver Grundmann; Walter C. Prozialeck; Charles Veltri; Giuseppe Bersani; Ornella Corazza

doi:10.3389/fpsyt.2020.594816

Can Kratom (Mitragyna speciosa) Alleviate COVID-19 Pain? A Case Study

Antonio Metastasio
, Elisabeth Prevete
, Darshan Singh
, Oliver Grundmann
, Walter C. Prozialeck
, Charles Veltri
, Giuseppe Bersani
, Ornella Corazza

Research output: Contribution to journal › Article › peer-review

16 Citations (Scopus)

38 Downloads (Pure)

Abstract

Among the symptoms of COVID-19 fever, general malaise, pain and aches, myalgia, fatigue, and headache can affect the quality of life of patients, even after the end of the acute phase of the infection and can be long lasting. The current treatment of these symptoms, also because COVID-19 patients have been asked not to use non-steroidal anti-inflammatory drugs (NSAIDs), in particular ibuprofen are often unsatisfactory. Among the above mentioned symptoms malaise and fatigue seem the most difficult to treat. In this case report we describe the use of kratom (Mitragyna speciosa) by a patient with confirmed COVID-19 infection. What we observed was a fast and sustained relieve of the above mentioned symptoms.

Original language	English
Article number	594816
Number of pages	6
Journal	Frontiers in Psychiatry
Volume	11
DOIs	https://doi.org/10.3389/fpsyt.2020.594816
Publication status	Published - 19 Nov 2020

Keywords

COVID-19
kratom
long covid
new psychoactive substances
new treatments
opioid
stimulants

Access to Document

10.3389/fpsyt.2020.594816Licence: CC BY

fpsyt_11_594816
© 2020 Metastasio, Prevete, Singh, Grundmann, Prozialeck, Veltri, Bersani and Corazza. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY - https://creativecommons.org/licenses/by/4.0/). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Final published version, 200 KBLicence: CC BY

Cite this

@article{27a8963c305242c285053615b08f7342,

title = "Can Kratom (Mitragyna speciosa) Alleviate COVID-19 Pain? A Case Study",

abstract = "Among the symptoms of COVID-19 fever, general malaise, pain and aches, myalgia, fatigue, and headache can affect the quality of life of patients, even after the end of the acute phase of the infection and can be long lasting. The current treatment of these symptoms, also because COVID-19 patients have been asked not to use non-steroidal anti-inflammatory drugs (NSAIDs), in particular ibuprofen are often unsatisfactory. Among the above mentioned symptoms malaise and fatigue seem the most difficult to treat. In this case report we describe the use of kratom (Mitragyna speciosa) by a patient with confirmed COVID-19 infection. What we observed was a fast and sustained relieve of the above mentioned symptoms.",

keywords = "COVID-19, kratom, long covid, new psychoactive substances, new treatments, opioid, stimulants",

author = "Antonio Metastasio and Elisabeth Prevete and Darshan Singh and Oliver Grundmann and Prozialeck, \{Walter C.\} and Charles Veltri and Giuseppe Bersani and Ornella Corazza",

note = "{\textcopyright} 2020 Metastasio, Prevete, Singh, Grundmann, Prozialeck, Veltri, Bersani and Corazza. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY - https://creativecommons.org/licenses/by/4.0/). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.",

year = "2020",

month = nov,

day = "19",

doi = "10.3389/fpsyt.2020.594816",

language = "English",

volume = "11",

journal = "Frontiers in Psychiatry",

issn = "1664-0640",

publisher = "Frontiers Media S.A.",

}

TY - JOUR

T1 - Can Kratom (Mitragyna speciosa) Alleviate COVID-19 Pain? A Case Study

AU - Metastasio, Antonio

AU - Prevete, Elisabeth

AU - Singh, Darshan

AU - Grundmann, Oliver

AU - Prozialeck, Walter C.

AU - Veltri, Charles

AU - Bersani, Giuseppe

AU - Corazza, Ornella

N1 - © 2020 Metastasio, Prevete, Singh, Grundmann, Prozialeck, Veltri, Bersani and Corazza. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY - https://creativecommons.org/licenses/by/4.0/). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PY - 2020/11/19

Y1 - 2020/11/19

N2 - Among the symptoms of COVID-19 fever, general malaise, pain and aches, myalgia, fatigue, and headache can affect the quality of life of patients, even after the end of the acute phase of the infection and can be long lasting. The current treatment of these symptoms, also because COVID-19 patients have been asked not to use non-steroidal anti-inflammatory drugs (NSAIDs), in particular ibuprofen are often unsatisfactory. Among the above mentioned symptoms malaise and fatigue seem the most difficult to treat. In this case report we describe the use of kratom (Mitragyna speciosa) by a patient with confirmed COVID-19 infection. What we observed was a fast and sustained relieve of the above mentioned symptoms.

AB - Among the symptoms of COVID-19 fever, general malaise, pain and aches, myalgia, fatigue, and headache can affect the quality of life of patients, even after the end of the acute phase of the infection and can be long lasting. The current treatment of these symptoms, also because COVID-19 patients have been asked not to use non-steroidal anti-inflammatory drugs (NSAIDs), in particular ibuprofen are often unsatisfactory. Among the above mentioned symptoms malaise and fatigue seem the most difficult to treat. In this case report we describe the use of kratom (Mitragyna speciosa) by a patient with confirmed COVID-19 infection. What we observed was a fast and sustained relieve of the above mentioned symptoms.

KW - COVID-19

KW - kratom

KW - long covid

KW - new psychoactive substances

KW - new treatments

KW - opioid

KW - stimulants

UR - https://www.scopus.com/pages/publications/85097223872

U2 - 10.3389/fpsyt.2020.594816

DO - 10.3389/fpsyt.2020.594816

M3 - Article

C2 - 33329145

AN - SCOPUS:85097223872

SN - 1664-0640

VL - 11

JO - Frontiers in Psychiatry

JF - Frontiers in Psychiatry

M1 - 594816

ER -

Can Kratom (Mitragyna speciosa) Alleviate COVID-19 Pain? A Case Study

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this